If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Patient Focused Services » Patient Advocacy Groups
Download FREE Excerpt
66 Info Graphics
36 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Consequently, the pharma groups that engage patient advocacy groups continue to evolve and adopt a more collaborative role with the companies’ Medical, Commercial, and Government and Corporate Affairs teams.
Best Practices, LLC conducted benchmarking research to highlight effective practices in patient advocacy group collaboration and relationship management.
This report examines ideal structures and skill sets for pharma groups that deal with advocacy groups, investment and resource levels, regulatory impact, top challenges, and emerging trends that will define the future of successful manufacturer-advocacy collaboration.
Research insights are segmented on the basis of reporting function of benchmark partners to provide a clear understanding of the impact of organizational decisions on patient advocacy trends.
Best Practices, LLC engaged 63 leaders supporting patient advocacy at 49 biopharmaceutical companies through a benchmarking survey. More than 70% of benchmark partners are at the director level. At least 70% of benchmark partners are from the United States.
Data in this research is segmented on the basis of reporting structure to offer a clear understanding of the impact of organizational decisions on patient advocacy trends. Research data is presented into the following segments: Total Benchmark Class (N=63), Reports to Commercial (N=12), Reports to Medical Affairs (N=14), Reports to Government and Corporate Affairs (N=20) and Reports to C-Suite (N=10).
Key topics covered in this report include: